Last week Syneron Medical announced the acquisition of Ultrashape Ltd. a “leading developer, manufacturer and marketer of innovative non-invasive technologies for fat cell destruction and body sculpting” for the bargain price of $12 million. The Ultrashape device uses focused ultrasonic energy to treat pockets of fatty tissue in order to achieve smooth body contouring results. While the treatment is not yet approved in the United States, Ultrashape is widely available in Europe, Asia and Canada.
This is not the first major acquisition the Israel-based Syneron has made recently, in late 2009, Syneron bought Candela Lasers making Syneron the largest aesthetic laser manufacturer in the world. Candela was widely known and respected among laser surgeons for their high quality equipment. The additions Syneron has made in purchasing Candela and Ultrashape are a clear indicator that Syneron is determined to maintain the standing at the top of the aesthetic device world.